E2F1 and lung adenocarcinoma: Subsequent survival analyses confirmed that overexpression of MYBL2 outperformed both E2F1 and FOXM1 transcription factors in identifying lung adenocarcinoma patients with poor outcomes (Figure 2, Figure S1).